Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

37.39
-2.5300-6.34%
Post-market: 37.390.00000.00%17:49 EDT
Volume:3.10M
Turnover:117.37M
Market Cap:2.19B
PE:-55.20
High:39.92
Open:39.92
Low:36.97
Close:39.92
52wk High:52.91
52wk Low:15.27
Shares:58.67M
Float Shares:58.19M
Volume Ratio:2.50
T/O Rate:5.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6773
EPS(LYR):-0.3410
ROE:-18.21%
ROA:-3.15%
PB:8.56
PE(LYR):-109.65

Loading ...

AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio

TIPRANKS
·
Yesterday

Axogen Completes Acquisition of BioCircuit Technologies

Reuters
·
Yesterday

AxoGen Completes Acquisition of Biocircuit Technologies, Adding Nervetape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

THOMSON REUTERS
·
Yesterday

Axogen Price Target Cut to $53.00/Share from $60.00 by Truist Securities

Dow Jones
·
Oct 01

AxoGen price target lowered to $53 from $60 at Truist

TIPRANKS
·
Oct 01

AxoGen, Inc. : Truist Securities Cuts Target Price to $53 from $60

THOMSON REUTERS
·
Oct 01

US Research Roundup-Amrize, Dexcom, Lennar

Reuters
·
Oct 01

Jefferies Reaffirms Their Buy Rating on AxoGen (AXGN)

TIPRANKS
·
Sep 29

AxoGen, Inc. : Raymond James Raises Target Price to $53 from $48

THOMSON REUTERS
·
Sep 25

US Research Roundup-Chevron, Exxon Mobil, GoDaddy

Reuters
·
Sep 25

Axogen Down over 10%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
Sep 11

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

MT Newswires Live
·
Sep 10

U.S. Stocks on the MOVE-Lovesac, Hagerty, Biohaven

Reuters
·
Sep 10

U.S. Stocks on the MOVE-AeroVironment, Macy's, Navan

Reuters
·
Sep 10

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

Reuters
·
Sep 10

Axogen Drops After Equity Raise for $200 Mln BioCircuit Acquisition

Reuters
·
Sep 10

Axogen Prices $208.7 Million Public Offering

MT Newswires Live
·
Sep 10

AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio

TIPRANKS
·
Sep 10

AxoGen Shares Down 5% Premarket After Announcing Public Offering of $208.7 Mln at Discounted Price of $42.5 Per Share; Co to Buy Biocircuit for $200 Mln

THOMSON REUTERS
·
Sep 10

Axogen to Buy NerveTape Maker BioCircuit for $200 Million

Dow Jones
·
Sep 10